CliffBio
small molecule

ZOLEDRONIC ACID

ZOLEDRONIC ACID

Loss of exclusivity—loss of exclusivity
CompanyShilpa Medicare →See this company's full patent-cliff portfolio

Drug detail

Brand nameZOLEDRONIC ACID
Active ingredientZOLEDRONIC ACID
StrengthEQ 4MG BASE/5ML
Dosage formINJECTABLE
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalMay 2019
Marketing statusDISCN

More from Shilpa Medicare

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

ZOLEDRONIC ACID patent cliff — loss of exclusivity — | CliffBio